Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05280574 · ClinicalTrials.gov registry record
The COSMOS Trial. A Pilot Study A Pilot Study
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 250
- Enrollment target
NCT05280574: Completed study, sponsored by The Cleveland Clinic.
NCT05280574 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05280574 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The investigators plan a pilot study to evaluate patient tolerance of the GE Portrait Mobile Monitoring Solution, along with appropriate alert thresholds, and clinical utility. Data obtained in the proposed pilot cohort will guide design of a future robust randomized trial comparing clinical interventions and serious complications with blinded versus unblinded continuous ward monitoring.
Primary Outcome
The vital sign abnormalities is a 5-component composite including the durations of SpO2 \<85%, heart rate \<45/min, heart rate \>130/min, respiratory rate \<4/min and respiratory rate \>30/min.
Interventions
- DEVICE Blinded GE Portrait Monitoring
- DEVICE Unblinded GE Portrait Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-08-10 |
| Est. Completion | 2023-08-30 |
What the finished NCT05280574 record still lists
NCT05280574 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Blinded GE Portrait Monitoring is the first listed.
NCT05280574 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05280574 about?
NCT05280574 is a clinical study titled "The COSMOS Trial. A Pilot Study A Pilot Study". The investigators plan a pilot study to evaluate patient tolerance of the GE Portrait Mobile Monitoring Solution, along with appropriate alert thresholds, and clinical utility. Data obtained in the proposed pilot cohort will guide design of a future robust randomized trial comparing clinical interve...
What is the current status of trial NCT05280574?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2022-08-10. Estimated completion is 2023-08-30.
What interventions are being tested in trial NCT05280574?
The interventions under investigation include: Blinded GE Portrait Monitoring (DEVICE), Unblinded GE Portrait Monitoring (DEVICE).
Who is sponsoring clinical trial NCT05280574?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI